Entrada Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Entrada Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2020 to Q2 2024.
  • Entrada Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 37.2M shares, a 11.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 37.2M +3.95M +11.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 33.6M +448K +1.35% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 33.5M +2.01M +6.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 33.4M +1.97M +6.27% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 33.2M +1.87M +5.97% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 33.2M +1.82M +5.79% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 31.4M +112K +0.36% Dec 31, 2022 10-K 2024-03-13
Q3 2022 31.4M +29.7M +1764% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 31.4M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 31.4M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 31.3M +30.1M +2341% Dec 31, 2021 10-K 2023-03-06
Q3 2021 1.68M Sep 30, 2021 10-Q 2021-12-09
Q4 2020 1.28M Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.